To date, the BCL2 family research in AML has focused mainly on BCL2, and, though to a lesser extent, on MCL1 and BCL2L1. Nagy et al. [67] found that BCL2, BCL2A1, MCL1, and BAX were highly expressed in leukemia and lymphoma patients. This evidence concerns the gene MCL1 and acute myeloid leukemia.